Attenuation of ligand-induced activation of angiotensin II type 1 receptor signaling by the type 2 receptor via protein kinase C

被引:34
|
作者
Inuzuka, Takayuki [1 ]
Fujioka, Yoichiro [1 ]
Tsuda, Masumi [2 ]
Fujioka, Mari [1 ]
Satoh, Aya O. [1 ]
Horiuchi, Kosui [1 ]
Nishide, Shinya [1 ]
Nanbo, Asuka [1 ]
Tanaka, Shinya [2 ]
Ohba, Yusuke [1 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Cell Physiol, Sapporo, Hokkaido 0608638, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Sapporo, Hokkaido 0608638, Japan
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
基金
日本学术振兴会;
关键词
AT2; RECEPTOR; AT(1); MECHANISMS; EXPRESSION; PATHWAYS; GROWTH; MYD88; CELLS; AORTA;
D O I
10.1038/srep21613
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Angiotensin II (AII) type 2 receptor (AT2R) negatively regulates type 1 receptor (AT1R) signaling. However, the precise molecular mechanism of AT2R-mediated AT1R inhibition remains poorly understood. Here, we characterized the local and functional interaction of AT2R with AT1R. AT2R colocalized and formed a complex with AT1R at the plasma membrane, even in the absence of AII. Upon AII stimulation, the spatial arrangement of the complex was modulated, as confirmed by Forster resonance energy transfer (FRET) analysis, followed by AT2R internalization along with AT1R. AT2R internalization was specifically observed only in the presence of AT1R; AT2R alone could not be internalized. The AT1R-specific inhibitor losartan completely inhibited both the conformational change and the internalization of AT2R with AT1R, whereas the AT2R-specific inhibitor PD123319 partially hindered these phenomena, demonstrating that the activation of both receptors was indispensable for these effects. In addition, treatment with the protein kinase C (PKC) inhibitors inhibited the ligand-dependent accumulation of AT2R but not that of AT1R in the endosomes. A mutation in the putative phosphorylation sites of AT2R also abrogated the co-internalization of ATR2 with AT1R and the inhibitory effect of ATR2 on AT1R. These data suggest that AT2R inhibits ligand-induced AT1R signaling through the PKC-dependent pathway.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition
    Siddiquee, K.
    Hampton, J.
    McAnally, D.
    May, L. T.
    Smith, L. H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (05) : 1104 - 1117
  • [22] A Semisynthetic Eph Receptor Tyrosine Kinase Provides Insight into Ligand-Induced Kinase Activation
    Singla, Nikhil
    Erdjument-Bromage, Hediye
    Himanen, Juha P.
    Muir, Tom W.
    Nikolov, Dimitar B.
    CHEMISTRY & BIOLOGY, 2011, 18 (03): : 361 - 371
  • [23] The angiotensin II type 2 receptor in renal disease
    Wenzel, Ulrich Otto
    Krebs, Christian
    Benndorf, Ralf
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2010, 11 (01) : 37 - 41
  • [24] Type II cGMP-dependent protein kinase inhibits ligand-induced activation of EGFR in gastric cancer cells
    Jiang, Lu
    Chen, Yongchang
    Li, Yueying
    Lan, Ting
    Wu, Min
    Wang, Ying
    Qian, Hai
    MOLECULAR MEDICINE REPORTS, 2014, 9 (04) : 1405 - 1409
  • [25] The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling
    Gao, Shuman
    Wang, Zhiqiang
    Wang, Wencai
    Hu, Xueli
    Chen, Peilin
    Li, Jiwen
    Feng, Xinhua
    Wong, Jiemin
    Du, James X.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (30) : 12702 - 12712
  • [26] Interplay between intracellular loop 1 and helix VIII of the angiotensin II type 2 receptor controls its activation
    Connolly, Alexandre
    Holleran, Brian J.
    Simard, Elie
    Baillargeon, Jean-Patrice
    Lavigne, Pierre
    Leduc, Richard
    BIOCHEMICAL PHARMACOLOGY, 2019, 168 : 330 - 338
  • [27] Exploration of Angiotensin II Type 1 Receptor Modulators by Molecular Fingerprints and Docking Simulations
    Niazi, Sarfaraj
    Hebbar, Vishwamohana M.
    Mathew, Pooja
    Kumar, Raj K. D.
    Purohit, Madhusudan
    LETTERS IN DRUG DESIGN & DISCOVERY, 2018, 15 (01) : 95 - 102
  • [28] Angiotensin-II Type 1 Receptor-Mediated Janus Kinase 2 Activation Induces Liver Fibrosis
    Granzow, Michaela
    Schierwagen, Robert
    Klein, Sabine
    Kowallick, Benita
    Huss, Sebastian
    Linhart, Markus
    Mazar, Irela G. Reza
    Goertzen, Jan
    Vogt, Annabelle
    Schildberg, Frank A.
    Gonzalez-Carmona, Maria A.
    Wojtalla, Alexandra
    Kraemer, Benjamin
    Nattermann, Jacob
    Siegmund, Soeren V.
    Werner, Nikos
    Fuerst, Dieter O.
    Laleman, Wim
    Knolle, Percy
    Shah, Vijay H.
    Sauerbruch, Tilman
    Trebicka, Jonel
    HEPATOLOGY, 2014, 60 (01) : 334 - 348
  • [29] The angiotensin II type 2 receptor in cardiovascular disease
    Lemarie, Catherine A.
    Schiffrin, Ernesto L.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2010, 11 (01) : 19 - 31
  • [30] Ligand-induced activation and G protein coupling of prostaglandin F2α receptor
    Wu, Canrong
    Xu, Youwei
    He, Qian
    Li, Dianrong
    Duan, Jia
    Li, Changyao
    You, Chongzhao
    Chen, Han
    Fan, Weiliang
    Jiang, Yi
    Eric Xu, H.
    NATURE COMMUNICATIONS, 2023, 14 (01)